PureTech Health plc

Transaction in Own Shares • Dec 19, 2023

National Storage Mechanism | Additional information

RNS Number : 2172X

PureTech Health PLC

19 December 2023

19 December 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	18 December 2023
Number of ordinary shares purchased:	51,345
Highest price paid per share:	150.80p
Lowest price paid per share:	148.00p
Volume weighted average price paid per share:	150.04p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,394,375 ordinary shares in treasury and has 272,073,784 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,073,784 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
18/12/2023	08:14:43	770	148	XLON	00382815671TRLO0.1.1
18/12/2023	08:22:01	770	148	XLON	00382816554TRLO0.1.1
18/12/2023	08:29:23	770	148	XLON	00382817362TRLO0.1.1
18/12/2023	08:37:07	1	148.6	CHIX	00382818057TRLO0.1.1
18/12/2023	08:37:07	20	148.6	CHIX	00382818058TRLO0.1.1
18/12/2023	08:37:07	217	148.6	CHIX	00382818059TRLO0.1.1
18/12/2023	08:37:23	770	148.6	XLON	00382818086TRLO0.1.1
18/12/2023	08:52:32	770	150	XLON	00382819525TRLO0.1.1
18/12/2023	08:53:20	770	150	XLON	00382819682TRLO0.1.1
18/12/2023	08:57:04	762	150	CHIX	00382820271TRLO0.1.1
18/12/2023	09:00:59	770	150	XLON	00382821056TRLO0.1.1
18/12/2023	09:24:44	688	150.6	CHIX	00382824568TRLO0.1.1
18/12/2023	09:24:44	574	150.6	XLON	00382824569TRLO0.1.1
18/12/2023	09:50:28	966	150.4	XLON	00382827134TRLO0.1.1
18/12/2023	09:50:28	126	150.4	XLON	00382827135TRLO0.1.1
18/12/2023	09:50:28	329	150.4	AQXE	00382827136TRLO0.1.1
18/12/2023	09:50:28	631	150.2	BATE	00382827137TRLO0.1.1
18/12/2023	09:50:28	153	150.2	TRQX	00382827138TRLO0.1.1
18/12/2023	09:50:28	21	150.2	TRQX	00382827139TRLO0.1.1
18/12/2023	10:00:41	622	150.2	CHIX	00382828324TRLO0.1.1
18/12/2023	10:00:41	644	150.2	XLON	00382828325TRLO0.1.1
18/12/2023	10:36:12	770	150.2	CHIX	00382831645TRLO0.1.1
18/12/2023	10:36:13	235	150.2	XLON	00382831649TRLO0.1.1
18/12/2023	10:37:08	10	150.2	XLON	00382831703TRLO0.1.1
18/12/2023	12:22:46	329	150.2	AQXE	00382843407TRLO0.1.1
18/12/2023	12:22:46	770	150.2	CHIX	00382843408TRLO0.1.1
18/12/2023	12:39:07	111	150	BATE	00382845644TRLO0.1.1
18/12/2023	12:39:07	520	150	BATE	00382845645TRLO0.1.1
18/12/2023	12:39:07	56	150	BATE	00382845646TRLO0.1.1
18/12/2023	12:39:07	24	150	TRQX	00382845647TRLO0.1.1
18/12/2023	12:39:07	174	150	TRQX	00382845648TRLO0.1.1
18/12/2023	12:39:07	16	150	TRQX	00382845649TRLO0.1.1
18/12/2023	12:39:07	1540	150	XLON	00382845650TRLO0.1.1
18/12/2023	12:45:35	1540	149.6	XLON	00382847484TRLO0.1.1
18/12/2023	14:30:02	329	150.2	AQXE	00382866352TRLO0.1.1
18/12/2023	14:30:02	329	150.2	AQXE	00382866355TRLO0.1.1
18/12/2023	14:30:02	20	150.2	AQXE	00382866357TRLO0.1.1
18/12/2023	14:30:02	120	150.2	CHIX	00382866360TRLO0.1.1
18/12/2023	14:30:02	73	150.2	CHIX	00382866362TRLO0.1.1
18/12/2023	14:30:02	105	150.2	CHIX	00382866363TRLO0.1.1
18/12/2023	14:30:02	472	150.2	CHIX	00382866366TRLO0.1.1
18/12/2023	14:30:02	770	150.2	CHIX	00382866368TRLO0.1.1
18/12/2023	14:30:02	28	150.2	TRQX	00382866370TRLO0.1.1
18/12/2023	14:30:02	106	150.2	TRQX	00382866372TRLO0.1.1
18/12/2023	14:30:02	2	150.2	TRQX	00382866374TRLO0.1.1
18/12/2023	14:30:02	63	150.2	TRQX	00382866389TRLO0.1.1
18/12/2023	14:30:02	28	150.2	TRQX	00382866391TRLO0.1.1
18/12/2023	14:30:07	615	150.6	CHIX	00382867655TRLO0.1.1
18/12/2023	14:30:07	49	150.8	CHIX	00382867659TRLO0.1.1
18/12/2023	14:30:07	35	150.8	CHIX	00382867662TRLO0.1.1
18/12/2023	14:30:07	178	150.8	CHIX	00382867664TRLO0.1.1
18/12/2023	14:30:44	217	150.8	CHIX	00382873289TRLO0.1.1
18/12/2023	14:30:44	60	150.8	CHIX	00382873290TRLO0.1.1
18/12/2023	14:36:18	217	150.8	CHIX	00382889704TRLO0.1.1
18/12/2023	14:36:53	217	150.8	CHIX	00382890776TRLO0.1.1
18/12/2023	14:37:28	217	150.8	CHIX	00382891973TRLO0.1.1
18/12/2023	14:39:07	217	150.8	CHIX	00382895034TRLO0.1.1
18/12/2023	14:39:07	41	150.8	CHIX	00382895036TRLO0.1.1
18/12/2023	14:42:41	217	150.8	CHIX	00382899790TRLO0.1.1
18/12/2023	14:42:41	58	150.8	CHIX	00382899791TRLO0.1.1
18/12/2023	14:43:14	217	150.8	CHIX	00382900533TRLO0.1.1
18/12/2023	14:45:27	575	150.8	BATE	00382903494TRLO0.1.1
18/12/2023	14:52:42	309	150.8	AQXE	00382910658TRLO0.1.1
18/12/2023	14:52:42	1295	150.8	CHIX	00382910659TRLO0.1.1
18/12/2023	14:52:42	255	150.8	TRQX	00382910660TRLO0.1.1
18/12/2023	14:59:16	631	150.8	BATE	00382916333TRLO0.1.1
18/12/2023	15:26:07	210	150.4	AQXE	00382933268TRLO0.1.1
18/12/2023	15:38:43	143	150.4	CHIX	00382939427TRLO0.1.1
18/12/2023	15:38:43	770	150.4	CHIX	00382939428TRLO0.1.1
18/12/2023	15:38:43	119	150.4	AQXE	00382939429TRLO0.1.1
18/12/2023	15:38:43	71	150.4	CHIX	00382939430TRLO0.1.1
18/12/2023	15:38:43	631	150.4	BATE	00382939431TRLO0.1.1
18/12/2023	15:38:43	174	150.4	TRQX	00382939432TRLO0.1.1
18/12/2023	15:38:46	1654	150	XLON	00382939498TRLO0.1.1
18/12/2023	15:38:46	1392	150	XLON	00382939499TRLO0.1.1
18/12/2023	15:38:46	1392	150	XLON	00382939500TRLO0.1.1
18/12/2023	15:38:46	1654	150	XLON	00382939501TRLO0.1.1
18/12/2023	15:44:05	329	150.2	AQXE	00382941981TRLO0.1.1
18/12/2023	15:44:07	1082	150	XLON	00382941995TRLO0.1.1
18/12/2023	15:56:58	329	150	AQXE	00382946911TRLO0.1.1
18/12/2023	15:56:58	631	150.2	BATE	00382946912TRLO0.1.1
18/12/2023	15:56:58	1326	150.2	CHIX	00382946913TRLO0.1.1
18/12/2023	15:56:58	770	150.2	CHIX	00382946914TRLO0.1.1
18/12/2023	15:56:58	631	150.2	BATE	00382946915TRLO0.1.1
18/12/2023	15:56:58	1964	150	XLON	00382946917TRLO0.1.1
18/12/2023	15:56:58	174	150.2	TRQX	00382946916TRLO0.1.1
18/12/2023	15:56:58	770	150	XLON	00382946918TRLO0.1.1
18/12/2023	15:56:58	276	150	XLON	00382946919TRLO0.1.1
18/12/2023	15:56:58	234	150	XLON	00382946920TRLO0.1.1
18/12/2023	15:56:58	260	150	XLON	00382946921TRLO0.1.1
18/12/2023	15:56:58	295	150	XLON	00382946922TRLO0.1.1
18/12/2023	15:56:58	475	150	XLON	00382946923TRLO0.1.1
18/12/2023	15:56:58	1835	150	XLON	00382946924TRLO0.1.1
18/12/2023	15:56:58	1211	150	XLON	00382946925TRLO0.1.1
18/12/2023	15:56:58	1160	150	XLON	00382946926TRLO0.1.1
18/12/2023	15:56:58	314	150	XLON	00382946927TRLO0.1.1
18/12/2023	15:56:58	636	150	XLON	00382946928TRLO0.1.1
18/12/2023	15:57:02	904	150	XLON	00382946978TRLO0.1.1
18/12/2023	15:57:28	1033	150	XLON	00382947151TRLO0.1.1
18/12/2023	15:57:28	1192	150	XLON	00382947150TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFVAFTLTLIV